COLO B Coloplast A/S Class B

Coloplast A/S - Transactions in connection with share buy-back programme, week 29

Coloplast A/S - Transactions in connection with share buy-back programme, week 29

As mentioned in Announcement no. 02/2021 Coloplast is initiating a share buyback programme totalling up to DKK 500 million.

The programme commenced on 22 February 2021 and is expected to end by 23 August 2021.

The share buyback programme is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations with the purpose of meeting obligations arising from share options programmes or other allocation of shares to employees or to complete a share capital decrease as set out in Articles 5(2)(a) and 5(2)(c) in MAR.

The following transactions have been executed during the period 19 – 23 July 2021:

DateNumber of sharesAverage purchase price, DKKTransaction value, DKK
19 July 20212001,091.04218,208
20 July 20213001,093.04327,912
21 July 202111,0001,100.5512,106,050
22 July 20211501,103.17165,476
23 July 20213001,117.02335,106
Accumulated until now under the programme411,048975.29400,891,662

Henceforth, Coloplast owns 3,229,384 treasury B shares of DKK 1 equal to 1.50% of the company’s total share capital.

An overview showing the transaction data for the period 19 – 23 July 2021 is enclosed.

Kind regards,

Investor Relations

Coloplast A/S

Tel. +45 4911 1800

 

For further information, please contact

  

Investors and analysts

Anders Lonning-Skovgaard

Executive Vice President, CFO

Tel. +45 4911 1111

Ellen Bjurgert

Vice President, Investor Relations

Tel. +45 4911 1800 /+45 4911 3376

Email: [email protected]

Aleksandra Dimovska

Sr. Manager, Investor Relations

Tel. +45 4911 1800 / +45 4911 2458

Email: [email protected]                                                                       

Press and the media

Peter Mønster

Sr. Media Relations Manager

Tel. +45 4911 2623

Email: [email protected]

Address

Coloplast A/S

Holtedam 1

DK-3050 Humlebaek

Denmark

Company reg. (CVR) no. 69749917

Website

www.coloplast.com



This announcement is available in a Danish and an English-language version. In the event of discrepancies, the Danish version shall prevail.

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate health care. Our business includes Ostomy Care, Continence Care, Wound and Skin Care and Interventional Urology. We operate globally and employ about 12,500 employees.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2021-07.

All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.

Attachments



EN
26/07/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Coloplast A/S Class B

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
 PRESS RELEASE

Coloplast A/S – Updated presenters list for Capital Markets Day on 2 S...

Coloplast A/S – Updated presenters list for Capital Markets Day on 2 September 2025 Following the changes to the Executive Leadership Team, announced on 19.08.2025*, we are pleased to share with you the updated presenters list for our Capital Markets Day on 2 September 2025. For those of you who have signed up, we look forward to seeing you at the event.  The event will take place on Tuesday, 2 September 2025 at Clarion Hotel (Copenhagen airport)Ellehammersvej 20, 2770 Kastrupfrom 10.30 - 17.00 CEST(Central European Summer Time) The event will be held in person at Clarion Hotel in Copenh...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch